NIH Funding Opportunities (Notices, PA, RFA)
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 21 min ago
Notice of Change to Key Dates for PAR-17-310, "Cellular and Molecular Biology of Complex Brain Disorders (R21)"
Notice NOT-MH-17-033 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIDA's Participation in PAR-15-054 "Alcohol Education Project Grants (R25)"
Notice NOT-DA-17-043 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
The NIH Common Fund Regenerative Medicine Program (RMP) Announces the Opportunity to Collaborate with the Stem Cell Translation Laboratory (SCTL) at the National Center for Advancing Translational Sciences (NCATS)
Notice NOT-RM-17-030 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Point of Care Technologies Research Network Centers (U54)
Notice NOT-EB-17-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NCCIH Natural Product Phase I-IIa Clinical Trial Award (R33)
Funding Opportunity PAR-17-318 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for investigator-initiated early phase clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product.
Categories: Job Watch, Literature Watch
NCCIH Natural Product Phase I-IIa Clinical Trial Phased Innovation Award (R61/R33)
Funding Opportunity PAR-17-319 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for investigator-initiated early phase clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product.
Categories: Job Watch, Literature Watch
Ruth L. Kirschstein National Research Service Awards (NRSA) Predoctoral Stipends, Training Related Expenses, Institutional Allowance, and Tuition/Fees Effective for Fiscal Year 2017
Notice NOT-OD-17-072 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates in PA-17-292, "HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R21)"
Notice NOT-AI-17-032 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIDCR's Withdrawal from Participation in PA-16-040 "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)"
Notice NOT-DE-17-011 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Human Studies of Target Identification, Biomarkers and Disease Mechanisms Specific to Small Blood and Lymphatic Vessels in the CNS and Retina) (R01)
Notice NOT-NS-17-031 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Innovative Approaches or Technologies to Investigate Regional, Structural and Functional Heterogeneity of Small Blood and Lymphatic Vessels in the CNS and Retina (R01)
Notice NOT-NS-17-030 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV Data Coordinating Center (HLB SIMPLe DCC) (U24)
Notice NOT-HL-17-521 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Heart, Lung, and Blood Co-morbiditieS Implementation Models in People Living with HIV (HLB SIMPLe) (U01)
Notice NOT-HL-17-520 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Extend Application Deadline-Creation and Implementation of the National Evaluation System for Health Technology (NEST) Coordination Center (CC)
Notice NOT-FD-18-001 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Revision: Notice of Extension of Effective Date for Final NIH Policy on the Use of Single Institution Review Board for Multi-Site Research
Notice NOT-OD-17-076 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Pre-Application Webinar for RFA-AR-18-004, NIAMS Rheumatic Diseases Research Resource-based Centers
Notice NOT-AR-17-017 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Availability of Administrative Supplements for CTSA Awardees: Development of Resources to Facilitate Single IRB Review for Multi-Site Research
Notice NOT-TR-17-018 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Collaborative Activities to Expedite Environmental Health Science Research, Translation, and Community Engagement Across EHS Core Centers (Admin Supp)
Funding Opportunity PA-17-317 from the NIH Guide for Grants and Contracts. These administrative supplements provide funds to awarded P30 Environmental Health Sciences Core Centers to enhance interactions across Centers to address emerging issues and to advance research, translation, and community engagement.
Categories: Job Watch, Literature Watch
Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01)
Funding Opportunity RFA-DA-18-011 from the NIH Guide for Grants and Contracts. The National Institute on Drug Abuse supported a number of HIV/AIDS cohorts among substance abusing populations. These cohorts address emerging and high priority research on HIV/AIDS. These longitudinal cohorts serve as a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV infection, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and efficiency of investigator-initiated research. Accomplishments by the NIDA-funded cohorts have been highly significant. Four of these cohorts (see below) will be terminated within a year if continued support is not provided. Therefore, the purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to support the maintenance and expansion of these NIDA-funded cohorts to continue to address new emerging and/or high priority research on multidisciplinary aspects of HIV/AIDS and substance abuse. This FOA will provide continued support for recruiting and retaining participants in the cohort(s) to provide insight into the changing demographics of the HIV epidemic among this high risk population in the United States (U.S.). This FOA will also continue to provide a strong resource platform for current and future collaborative efforts with other investigators to address new and emerging questions related to HIV infection, prevention, and/or treatment in the context of substance abuse, as well as to foster the creativity and efficiency of investigatorinitiated research goals.
Categories: Job Watch, Literature Watch
Notice of Additional Receipt Date for PAR-17-270 "NIDDK Central Repositories Non-renewable Sample Access (X01)"
Notice NOT-DK-17-013 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch